In the context of esophageal cancer, OPCML’s downregulation in Grade 3 tumors may implicate its regulatory role in the Wnt/β-catenin signalling pathway, potentially contributing to the development and progression of higher-grade tumors [139]. The gene discussed is OPCML; the disease is esophageal cancer.